In the rapidly evolving landscape of synthetic glycobiology, the selection and optimization of the chassis is the cornerstone of commercial success. At CD BioGlyco, we recognize that even the most sophisticated metabolic engineering strategy fails if the underlying host strain harbors genetic instabilities or metabolic bottlenecks. Our chassis strain validation service provides a rigorous, data-driven assessment of microbial, yeast, and mammalian cell factories. By integrating high-throughput sequencing with advanced bioinformatics, we ensure that your engineered strains meet the exacting standards required for high-titer production of glycans, glycoproteins, and glycolipids. Whether you are developing a novel Escherichia coli or optimizing a complex Pichia pastoris system, our validation services bridge the gap between laboratory-scale design and industrial-scale reality.
Key Technologies
1. Next-Generation Sequencing (NGS)
We utilize high-depth NGS to provide a view of the chassis genome. Unlike traditional methods, NGS allows for the detection of low-frequency mutations, structural variations, and off-target integrations that could compromise long-term strain stability during fermentation.
2. Single-Molecule Sequencing
For complex chassis with highly repetitive regions or GC-rich content, we leverage single-molecule sequencing. This long-read technology is essential for generating de novo assemblies of synthetic chromosomes, ensuring that large-scale genetic insertions or clusters are correctly oriented and intact.
Empowering Your Synthetic Biology Pipeline with Multi-Layered Chassis Strain Validation
At CD BioGlyco, our chassis strain validation service is designed to provide an exhaustive molecular audit of your production hosts. As a subset of our specialized validation portfolio, we offer both cutting-edge sequencing and high-throughput hybridization technologies to ensure your strain is fit for purpose.
Chip Sequencing-based Chassis Validation Service
Our chip sequencing-based chassis validation service utilizes high-density DNA microarrays and ChIP-seq technologies to provide targeted, high-throughput validation of genetic stability and regulatory networks. This service is particularly vital for projects where the spatial organization of the genome or the binding efficiency of transcription factors is critical to product yield. By leveraging chip-based hybridization, we rapidly screen thousands of specific genomic markers across multiple strain variants simultaneously. This allows for the precise mapping of protein-DNA interactions, ensuring that your synthetic promoters and regulatory circuits are functioning as designed within the chassis. It is an ideal solution for large-scale strain libraries where traditional whole-genome approaches might be cost-prohibitive for initial screening phases.
We perform deep sequencing of the entire host genome to identify single nucleotide polymorphisms (SNPs), small insertions/deletions (indels), and large-scale genomic rearrangements. This is critical when transitioning from a wild-type strain to a "clean-genome" chassis. By mapping the reads against a reference or performing de novo assembly, we confirm the presence of all intended genetic modifications while screening for deleterious spontaneous mutations that might affect growth kinetics or product yield.
RNA Sequencing (RNA-Seq)-based Chassis Validation
Our RNA-Seq services provide a dynamic snapshot of the chassis's metabolic state. By analyzing the transcriptome under simulated production conditions, we identify transcriptional bottlenecks, unintended pathway cross-talk, and stress responses triggered by the heterologous production of complex glycans. This functional validation allows researchers to fine-tune promoter strengths and optimize nutrient utilization, ensuring the chassis remains robust during high-density cultivation.
Targeted Sequencing-based Chassis Validation
For projects involving multi-copy gene integration or specific metabolic clusters, targeted sequencing offers a cost-effective and highly sensitive alternative to WGS. We focus on specific loci, such as integrated glycosyltransferase pathways or antibiotic resistance markers, to verify copy number variation (CNV) and sequence fidelity. This is particularly useful for longitudinal studies where strain stability is monitored across multiple generations of continuous fermentation.
Through these integrated genomic approaches, CD BioGlyco provides the granular data necessary to de-risk your development process. Our validation reports include bioinformatic analysis, highlighting potential risks and suggesting optimization strategies for your specific glycobiology applications.
Workflow
Consultation and Project Scoping
We begin with a detailed discussion of your chassis's history and your production goals. Our experts help define the necessary depth of coverage and the most appropriate sequencing modality (WGS, RNA-Seq, or targeted) based on the complexity of your modifications.
High-Quality Genomic Extraction
Using optimized lysis protocols tailored to specific cell types, including yeast, bacteria, and filamentous fungi, we extract high-molecular-weight DNA or total RNA. Rigorous quality control (QC) ensures that only the purest samples proceed to library preparation.
Library Preparation and Sequencing
Libraries are constructed using state-of-the-art kits to minimize bias. We then perform sequencing on high-throughput platforms, ensuring sufficient data density to capture rare genetic variants or low-abundance transcripts.
Advanced Bioinformatic Analysis
Our computational team processes the raw data, performing alignment, variant calling, and differential expression analysis. We specialize in identifying structural variants that standard pipelines often overlook, such as tandem duplications or inversions.
Comprehensive Validation Reporting
The final deliverable is a detailed report that interprets the genomic data in the context of your biological objectives. We provide clear visualizations, including circular genome maps and heatmaps of metabolic pathway expression.
Post-Validation Consulting
Following report delivery, we offer a technical consultation to discuss the implications of our findings. If instabilities are found, we provide actionable recommendations for strain re-engineering or stabilization.
Publication Data
DoI: 10.1038/s41598-020-62364-6
Journal: Scientific Reports
IF: 3.9
Published: 2020
Results: This study explores the potential and challenges of WGS for routine laboratory strain verification. Using haploid yeast segregants from a commercial mutant collection (with unexpected cell cycle phenotypes) as a test case, WGS identified eight unforeseen SNPs (four in cell cycle-related genes) and a transposon insertion in the WHI5 gene, likely causing the unexpected phenotype. The research reveals critical limitations: existing bioinformatics tools (e.g., GATK, Samtools, CNVnator) are ill-suited for microbial strain verification, often missing known indels or producing inconsistent results. Additionally, the lack of finished reference genomes for common strains (e.g., BY4741) hinders accurate comparisons. While WGS shows promise for detecting contamination, mix-ups, and secondary mutations, the study emphasizes the need for optimized tools, improved reference genomes, and streamlined workflows to integrate WGS into standard quality control, enhancing experimental reproducibility in life sciences.
Fig.1 Data analysis pipeline. (Gallegos, et al., 2020)
Applications
Recombinant Glycoprotein Production
Validate mammalian or yeast chassis used for therapeutic antibodies. We ensure that the glycosylation machinery is genetically stable, preventing batch-to-batch variation in glycan profiles and maintaining drug efficacy.
Metabolic Engineering
Confirm the integrity of complex biosynthetic pathways in E. coli or Bacillus subtilis. Our services verify that multiple gene insertions for human milk oligosaccharides (HMOs) production remain stable under industrial conditions.
Industrial Enzyme Manufacturing
Audit fungal chassis used for the secretion of glycosyl hydrolases. We identify transcriptional bottlenecks that limit protein secretion, allowing for the development of hyper-secreting strains for bio-industrial applications.
Vaccine Development
Ensure the genetic fidelity of bacterial hosts used in the production of glycoconjugate vaccines. Our targeted sequencing verifies the presence and stability of essential O-antigen clusters and carrier protein expressions.
Advantages
Exceptional Depth of Expertise
Our team consists of Ph.D.-level scientists specializing in synthetic glycobiology, ensuring that your data is interpreted by experts who understand the nuances of carbohydrate metabolism.
Cutting-Edge Sequencing
We utilize the latest NGS and long-read technologies to provide unparalleled resolution of your chassis's genome, catching errors that traditional methods miss entirely.
Customized Bioinformatic Pipelines
Unlike generic service providers, we use proprietary algorithms specifically tuned for synthetic biology, enabling the detection of complex synthetic constructs and repetitive genetic elements.
End-to-End Solutions
From initial extraction to post-sequencing strain optimization advice, CD BioGlyco offers a holistic service package that saves time and reduces the need for multiple vendors.
Frequently Asked Questions
Customer Review
"The genomic validation provided by CD BioGlyco was instrumental in our recent HMO project. They identified a silent mutation in our glycosyltransferase cluster that was impacting our yield. Their expertise in glycobiology made the data interpretation seamless."
– A.T., European Nutraceutical Firm
"We moved our chassis validation to CD BioGlyco because of their NGS capabilities. The depth of coverage and the quality of the bioinformatic report exceeded our expectations. It gave us the confidence to move forward."
– Z.F., North American Biopharma
"Fast, reliable, and scientifically rigorous. Their RNA-Seq analysis helped us troubleshoot a secretion bottleneck in our yeast platform that we had been struggling with for months."
The success of any glycobiology project depends on a rock-solid foundation. CD BioGlyco's chassis strain validation service offers the genomic and transcriptomic insights necessary to ensure your synthetic hosts are stable, productive, and ready for scale-up. Don't leave your strain's performance to chance—validate with the experts. Please feel free to contact us to provide technical support and tailored solutions for your validation needs.
Reference
Gallegos, J.E.; et al. Challenges and opportunities for strain verification by whole-genome sequencing. Scientific Reports. 2020, 10(1): 5873. (Open Access)
For research use only. Not intended for any clinical use.
Fig.1 Data analysis pipeline. (Gallegos, et al., 2020)
